• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆游离DNA中阿尔茨海默病线粒体DNA甲基化的特征分析

Characterization of Mitochondrial DNA Methylation of Alzheimer's Disease in Plasma Cell-Free DNA.

作者信息

Ding Binrong, Zhang Xuewei, Wan Zhengqing, Tian Feng, Ling Jie, Tan Jieqiong, Peng Xiaoqing

机构信息

Department of Geriatrics, The Third Xiangya Hospital, Central South University, Changsha 410000, China.

Health Management Center, Xiangya Hospital, Central South University, Changsha 410000, China.

出版信息

Diagnostics (Basel). 2023 Jul 12;13(14):2351. doi: 10.3390/diagnostics13142351.

DOI:10.3390/diagnostics13142351
PMID:37510095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10378411/
Abstract

Noninvasive diagnosis of Alzheimer's disease (AD) is important for patients. Significant differences in the methylation of mitochondrial DNA (mtDNA) were found in AD brain tissue. Cell-free DNA (cfDNA) is a noninvasive and economical diagnostic tool. We aimed to characterize mtDNA methylation alterations in the plasma cfDNA of 31 AD patients and 26 age- and sex-matched cognitively normal control subjects. We found that the mtDNA methylation patterns differed between AD patients and control subjects. The mtDNA was predominantly hypomethylated in the plasma cfDNA of AD patients. The hypomethylation sites or regions were mainly located in mt-rRNA, mt-tRNA, and D-Loop regions. The hypomethylation of the D-Loop region in plasma cfDNA of AD patients was consistent with that in previous studies. This study presents evidence that hypomethylation in the non-protein coding region of mtDNA may contribute to the pathogenesis of AD and potential application for the diagnosis of AD.

摘要

阿尔茨海默病(AD)的无创诊断对患者至关重要。在AD脑组织中发现线粒体DNA(mtDNA)甲基化存在显著差异。游离DNA(cfDNA)是一种无创且经济的诊断工具。我们旨在对31例AD患者及26例年龄和性别匹配的认知正常对照者血浆cfDNA中的mtDNA甲基化改变进行特征分析。我们发现AD患者与对照者之间的mtDNA甲基化模式不同。AD患者血浆cfDNA中的mtDNA主要呈低甲基化状态。低甲基化位点或区域主要位于mt - rRNA、mt - tRNA和D - 环区域。AD患者血浆cfDNA中D - 环区域的低甲基化与先前研究一致。本研究提供了证据表明mtDNA非编码区的低甲基化可能参与AD的发病机制,并具有AD诊断的潜在应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5039/10378411/33d02df12732/diagnostics-13-02351-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5039/10378411/900de9e3dea0/diagnostics-13-02351-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5039/10378411/04b0434952e5/diagnostics-13-02351-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5039/10378411/8096ef19297b/diagnostics-13-02351-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5039/10378411/85773262badf/diagnostics-13-02351-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5039/10378411/33d02df12732/diagnostics-13-02351-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5039/10378411/900de9e3dea0/diagnostics-13-02351-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5039/10378411/04b0434952e5/diagnostics-13-02351-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5039/10378411/8096ef19297b/diagnostics-13-02351-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5039/10378411/85773262badf/diagnostics-13-02351-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5039/10378411/33d02df12732/diagnostics-13-02351-g005.jpg

相似文献

1
Characterization of Mitochondrial DNA Methylation of Alzheimer's Disease in Plasma Cell-Free DNA.血浆游离DNA中阿尔茨海默病线粒体DNA甲基化的特征分析
Diagnostics (Basel). 2023 Jul 12;13(14):2351. doi: 10.3390/diagnostics13142351.
2
Alzheimer's Precision Neurology: Epigenetics of Cytochrome P450 Genes in Circulating Cell-Free DNA for Disease Prediction and Mechanism.阿尔茨海默病精准神经医学:循环无细胞游离 DNA 中细胞色素 P450 基因的表观遗传学用于疾病预测和机制研究。
Int J Mol Sci. 2023 Feb 2;24(3):2876. doi: 10.3390/ijms24032876.
3
5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.循环游离DNA中的5-羟甲基胞嘧啶特征作为晚发性阿尔茨海默病的诊断生物标志物
J Alzheimers Dis. 2022;85(2):573-585. doi: 10.3233/JAD-215217.
4
Decreased Methylation of the Mitochondrial D-Loop Region in Late-Onset Alzheimer's Disease.迟发性阿尔茨海默病中线粒体D-环区域甲基化降低
J Alzheimers Dis. 2017;59(2):559-564. doi: 10.3233/JAD-170139.
5
DNA hypomethylation of CBS promoter induced by folate deficiency is a potential noninvasive circulating biomarker for colorectal adenocarcinomas.叶酸缺乏诱导的CBS启动子DNA低甲基化是结直肠癌潜在的非侵入性循环生物标志物。
Oncotarget. 2017 May 18;8(31):51387-51401. doi: 10.18632/oncotarget.17988. eCollection 2017 Aug 1.
6
Altered mitochondrial DNA methylation and mitochondrial DNA copy number in an APP/PS1 transgenic mouse model of Alzheimer disease.阿尔茨海默病 APP/PS1 转基因小鼠模型中线粒体 DNA 甲基化和线粒体 DNA 拷贝数的改变。
Biochem Biophys Res Commun. 2019 Nov 26;520(1):41-46. doi: 10.1016/j.bbrc.2019.09.094. Epub 2019 Sep 26.
7
Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing.通过基于芯片的重测序技术对阿尔茨海默病患者群体和对照群体中鉴定出的线粒体DNA序列变异的异质性进行定量分析。
Mitochondrion. 2006 Aug;6(4):194-210. doi: 10.1016/j.mito.2006.07.002. Epub 2006 Jul 21.
8
Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease.线粒体 DNA 亚单倍群 h5 作为迟发性阿尔茨海默病危险因素的证据。
PLoS One. 2010 Aug 6;5(8):e12037. doi: 10.1371/journal.pone.0012037.
9
Elevated serum mitochondrial DNA in females and lack of altered platelet mitochondrial methylation in patients with Parkinson´s disease.女性血清中线粒体 DNA 升高,帕金森病患者血小板线粒体甲基化无改变。
Int J Neurosci. 2021 Mar;131(3):279-282. doi: 10.1080/00207454.2020.1738433. Epub 2020 Mar 11.
10
Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease.线粒体基因组对阿尔茨海默病中线粒体功能障碍的作用
J Alzheimers Dis. 2006 Jul;9(2):183-93. doi: 10.3233/jad-2006-9210.

引用本文的文献

1
Beyond the Blood Cell: The Emerging Role of Cell-Free DNA in Transfusion Medicine.超越血细胞:游离DNA在输血医学中的新兴作用
J Hematol. 2025 Jul 8;14(4):165-173. doi: 10.14740/jh2064. eCollection 2025 Aug.
2
Cell-Free DNA: Features and Attributes Shaping the Next Frontier in Liquid Biopsy.游离DNA:塑造液体活检下一个前沿领域的特征与属性
Mol Diagn Ther. 2025 May;29(3):277-290. doi: 10.1007/s40291-025-00773-x. Epub 2025 Apr 16.
3
The Potential of cfDNA as Biomarker: Opportunities and Challenges for Neurodegenerative Diseases.

本文引用的文献

1
Genome-wide characterization of mitochondrial DNA methylation in human brain.人类大脑中线粒体 DNA 甲基化的全基因组特征分析。
Front Endocrinol (Lausanne). 2023 Jan 16;13:1059120. doi: 10.3389/fendo.2022.1059120. eCollection 2022.
2
Nuclear-embedded mitochondrial DNA sequences in 66,083 human genomes.66083 个人类基因组中的核内线粒体 DNA 序列。
Nature. 2022 Nov;611(7934):105-114. doi: 10.1038/s41586-022-05288-7. Epub 2022 Oct 5.
3
Tracing the Origin of Cell-Free DNA Molecules through Tissue-Specific Epigenetic Signatures.
循环游离DNA作为生物标志物的潜力:神经退行性疾病面临的机遇与挑战
J Mol Neurosci. 2025 Mar 13;75(1):34. doi: 10.1007/s12031-025-02317-8.
4
Diagnostic role of circulating cell-free DNA in schizophrenia and neuro-degenerative disorders.循环游离DNA在精神分裂症和神经退行性疾病中的诊断作用。
Biomark Med. 2025 Mar;19(5):165-176. doi: 10.1080/17520363.2025.2468151. Epub 2025 Feb 24.
5
Whole-genome bisulfite sequencing of cell-free DNA unveils age-dependent and ALS-associated methylation alterations.游离DNA的全基因组亚硫酸氢盐测序揭示了年龄依赖性和肌萎缩侧索硬化症相关的甲基化改变。
Cell Biosci. 2025 Feb 20;15(1):26. doi: 10.1186/s13578-025-01366-1.
6
Environmental DNA Epigenetics Accurately Predicts the Age of Cultured Fish Larvae.环境DNA表观遗传学准确预测养殖鱼类幼体的年龄。
Ecol Evol. 2025 Feb 12;15(2):e70645. doi: 10.1002/ece3.70645. eCollection 2025 Feb.
7
Mitochondrial DNA (mtDNA) as fluid biomarker in neurodegenerative disorders: A systematic review.线粒体DNA(mtDNA)作为神经退行性疾病中的液体生物标志物:一项系统综述。
Eur J Neurol. 2025 Jan;32(1):e70014. doi: 10.1111/ene.70014.
8
Mitochondrial One-Carbon Metabolism and Alzheimer's Disease.线粒体一碳代谢与阿尔茨海默病。
Int J Mol Sci. 2024 Jun 7;25(12):6302. doi: 10.3390/ijms25126302.
9
Cell-Free DNA As Peripheral Biomarker of Alzheimer's Disease.游离DNA作为阿尔茨海默病的外周生物标志物
Aging Dis. 2024 Mar 29;16(2):787-803. doi: 10.14336/AD.2024.0329.
10
Mitochondria in Alzheimer's Disease Pathogenesis.线粒体在阿尔茨海默病发病机制中的作用
Life (Basel). 2024 Jan 30;14(2):196. doi: 10.3390/life14020196.
通过组织特异性表观遗传特征追踪游离DNA分子的起源
Diagnostics (Basel). 2022 Jul 29;12(8):1834. doi: 10.3390/diagnostics12081834.
4
Increase in Mitochondrial D-Loop Region Methylation Levels in Mild Cognitive Impairment Individuals.轻度认知障碍个体中线粒体 D 环区域甲基化水平升高。
Int J Mol Sci. 2022 May 12;23(10):5393. doi: 10.3390/ijms23105393.
5
Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease.将全身固有免疫细胞作为阿尔茨海默病的治疗途径
Pharmacol Rev. 2022 Jan;74(1):1-17. doi: 10.1124/pharmrev.121.000400.
6
Decreased mitochondrial D-loop region methylation mediates an increase in mitochondrial DNA copy number in CADASIL.线粒体 D 环区域甲基化减少介导 CADASIL 中线粒体 DNA 拷贝数的增加。
Clin Epigenetics. 2022 Jan 4;14(1):2. doi: 10.1186/s13148-021-01225-z.
7
Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer's disease brain.研究人类老年和阿尔茨海默病大脑中线粒体 DNA 数量和质量的特征。
Mol Neurodegener. 2021 Nov 6;16(1):75. doi: 10.1186/s13024-021-00495-8.
8
Role of Mitochondria in Neurodegenerative Diseases: From an Epigenetic Perspective.从表观遗传学角度看线粒体在神经退行性疾病中的作用
Front Cell Dev Biol. 2021 Aug 27;9:688789. doi: 10.3389/fcell.2021.688789. eCollection 2021.
9
Mitochondrial DNA Methylation and Human Diseases.线粒体 DNA 甲基化与人类疾病
Int J Mol Sci. 2021 Apr 27;22(9):4594. doi: 10.3390/ijms22094594.
10
Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer's disease.线粒体复合物 I 异常与轻度阿尔茨海默病中的 tau 蛋白和临床症状有关。
Mol Neurodegener. 2021 Apr 26;16(1):28. doi: 10.1186/s13024-021-00448-1.